1. Home
  2. COEP vs CPIX Comparison

COEP vs CPIX Comparison

Compare COEP & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • CPIX
  • Stock Information
  • Founded
  • COEP 2017
  • CPIX 1999
  • Country
  • COEP United States
  • CPIX United States
  • Employees
  • COEP N/A
  • CPIX N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • CPIX Biotechnology: Pharmaceutical Preparations
  • Sector
  • COEP Health Care
  • CPIX Health Care
  • Exchange
  • COEP Nasdaq
  • CPIX Nasdaq
  • Market Cap
  • COEP 32.4M
  • CPIX 68.7M
  • IPO Year
  • COEP N/A
  • CPIX 2009
  • Fundamental
  • Price
  • COEP $12.45
  • CPIX $5.15
  • Analyst Decision
  • COEP
  • CPIX
  • Analyst Count
  • COEP 0
  • CPIX 0
  • Target Price
  • COEP N/A
  • CPIX N/A
  • AVG Volume (30 Days)
  • COEP 111.8K
  • CPIX 4.2M
  • Earning Date
  • COEP 03-25-2025
  • CPIX 03-04-2025
  • Dividend Yield
  • COEP N/A
  • CPIX N/A
  • EPS Growth
  • COEP N/A
  • CPIX N/A
  • EPS
  • COEP N/A
  • CPIX N/A
  • Revenue
  • COEP N/A
  • CPIX $36,785,442.00
  • Revenue This Year
  • COEP N/A
  • CPIX N/A
  • Revenue Next Year
  • COEP N/A
  • CPIX N/A
  • P/E Ratio
  • COEP N/A
  • CPIX N/A
  • Revenue Growth
  • COEP N/A
  • CPIX N/A
  • 52 Week Low
  • COEP $2.31
  • CPIX $1.04
  • 52 Week High
  • COEP $13.70
  • CPIX $6.43
  • Technical
  • Relative Strength Index (RSI)
  • COEP 63.21
  • CPIX 68.22
  • Support Level
  • COEP $8.65
  • CPIX $4.12
  • Resistance Level
  • COEP $12.95
  • CPIX $5.29
  • Average True Range (ATR)
  • COEP 1.64
  • CPIX 0.74
  • MACD
  • COEP -0.16
  • CPIX 0.17
  • Stochastic Oscillator
  • COEP 75.25
  • CPIX 70.57

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

Share on Social Networks: